Literature DB >> 25481176

[Expression and immunogenicity analysis of truncated glycoprotein of infectious hematopoietic necrosis virus in fish].

Jingzhuang Zhao1, Liming Xu1, Miao Liu1, Yongsheng Cao1, Jiasheng Yin1, Hongbai Liu1, Tongyan Lu1.   

Abstract

OBJECTIVE: To investigate the immunogenicity of different regions of glycoproteins in fish infectious hematopoietic necrosis virus (IHNV).
METHODS: The glycoproteins was truncated and expressed according to the prediction of antigenicity and hydrophobicity by DNAStar 6.0 software. The protein was purified and used to produce antisera in rabbits. ELISA was performed to determine the antiserum titer and the immunogenicity of the protein was tested by indirect immunofluorescence assay (IFA).
RESULTS: SDS-PAGE showed that protein with expected size 40 kDa was obtained. Purity of the obtained protein was as high as 90% as confirmed by high performance liquid chromatography (HPLC) analysis. The antisera against glycoprotein prepared in this study could react specifically with both natural glycoprotein of the IHNV-Sn1203 and the recombinant truncated glycoprotein in ELISA test, and the antisera titer against the natural glycoprotein and the recombinant glycoprotein was 1:20 000 and 1:80 000, respectively. IFA result showed that the antisera could recognize the glycoprotein on the surface of IHNV-Sn1203 and reference strain IHNV-WRAC.
CONCLUSION: The antigenicity of the truncated glycoprotein produced in the study was as good as that of natural glycoprotein of IHNV.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25481176

Source DB:  PubMed          Journal:  Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi        ISSN: 1007-8738


  1 in total

1.  Bivalent DNA vaccine induces significant immune responses against infectious hematopoietic necrosis virus and infectious pancreatic necrosis virus in rainbow trout.

Authors:  Liming Xu; Jingzhuang Zhao; Miao Liu; Guangming Ren; Feng Jian; Jiasheng Yin; Ji Feng; Hongbai Liu; Tongyan Lu
Journal:  Sci Rep       Date:  2017-07-18       Impact factor: 4.379

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.